Shimadzu has announced that it will participate in the Yuichi Sugiyama Special Laboratory at RIKEN, supported by 26 Japanese companies, on micro-dose PET studies based on stable isotopes for clinical studies on humans unsing Shimadzu’s highly sensitive MS-MS system
Shimadzu press release, April 11, 2012
Shimadzu cooperates with Sugiyama Special Laboratory at RIKEN on human micro-dose studies using highly sensitive MS-MS